Kyowa Kirin Co., Ltd.

    Jurisdiction
    Japan
    LEI
    529900TBXKVTQGYA3582
    ISIN
    JP3256000005 (4151.T)
    Sectors
    1. Healthcare
    2. Drug Manufacturers - General

    Scores

    InsiderPie Expert Score
    50 / 100
    Even with peer group:
    51 / 100
    Fair value (Benjamin Graham formula)
    €8.96 44.0% overvalued
    Financial strength (Piotroski F-Value)
    6 / 9
    Fundamental strength relative to industry (Mohanram G-Value)
    5 / 7

    Profile

    Kyowa Kirin Co., Ltd. manufactures and markets pharmaceuticals that focuses on the therapeutic areas of oncology, nephrology, central nervous system, and immunology worldwide. Read full profile

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Fundamentals

    Net revenue
    €2.85B
    Gross margin
    72.6%
    EBIT
    €486.97M
    EBIT margin
    17.1%
    Net income
    €221.90M
    Net margin
    7.8%

    Statement period: - (published )

    Estimates

    Fiscal Year Net revenue Net income
    €2.90B +1.7% €387.38M +74.6%
    €3.04B +4.9% €412.94M +6.6%
    €3.17B +4.4% €480.46M +16.3%

    Dividends

    Last dividend amount
    ¥30.00
    Ex date
    Payment date
    Dividend payout ratio
    79.4%

    Earnings Calls

    Latest earnings call: August 1, 2025

    Add to watchlist

    Notifications